Mens dette er rapporteret oftere hos patienter med kronisk hepatitis C behandlet med interferon- alfa, er det også rapporteret hos patienter med onkologiske sygdomme behandlet med interferon- alfa.
While this has been reported more often in patients with chronic hepatitis C treated with interferon alpha, it has also been reported in patients with oncologic diseases treated with interferon alpha.